WB-LCP ORCHID OWNER LLC – Trademark Portfolio
Entity Type: 16
WB-LCP ORCHID OWNER LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include THE ORCHID AT MAUNA LANI and THE ORCHID AT MAUNA LANI ISLAND OF HAWAI'I. The owner is based in New York, NY.
1370 Avenue of the Americas, Suite 2800
New York, NY 10019
Showing of trademarks Trademarks
Trademark Classifications
WB-LCP ORCHID OWNER LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does WB-LCP ORCHID OWNER LLC have?
WB-LCP ORCHID OWNER LLC has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.
What trademark classes does WB-LCP ORCHID OWNER LLC file in?
WB-LCP ORCHID OWNER LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are WB-LCP ORCHID OWNER LLC's most well-known trademarks?
WB-LCP ORCHID OWNER LLC's registered trademark portfolio includes well-known marks such as THE ORCHID AT MAUNA LANI and THE ORCHID AT MAUNA LANI ISLAND OF HAWAI'I. These are among 3 currently registered trademarks in the portfolio.
What is WB-LCP ORCHID OWNER LLC's trademark registration success rate?
WB-LCP ORCHID OWNER LLC has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.